Related Experiment Video
Updated: Jul 19, 2026
08:44
Assembly and Characterization of Polyelectrolyte Complex Micelles
Published on: March 2, 2020
Controlled drug delivery system based on magnetic hollow spheres/polyelectrolyte multilayer core-shell structure
YanQi Zhang1, LinLin Lil, Fangqiong Tang
1Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100080, PR China.
Journal of Nanoscience and Nanotechnology
|October 20, 2006
Summary
Researchers developed a novel magnetic hollow sphere system for controlled drug delivery. This system provides sustained release of cefradine, with release rates tunable by pH, showing potential for targeted therapeutics.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Controlled drug delivery systems are crucial for therapeutic efficacy.
- Magnetic nanoparticles offer potential for targeted drug delivery.
- Chitosan/PAA multilayers provide a versatile platform for drug encapsulation.
Purpose of the Study:
- To fabricate a novel core-shell hollow structure for controlled drug delivery.
- To evaluate the drug release characteristics of the fabricated system.
- To investigate the potential of magnetic targeting in drug delivery therapeutics.
Main Methods:
- Fabrication of magnetic hollow spheres coated with chitosan/PAA multilayers using Layer-by-Layer (LBL) assembly.
- Encapsulation of cefradine as a model drug.
- Evaluation of drug release profiles under varying pH conditions.
Main Results:
- The core-shell hollow structure demonstrated sustained release of cefradine.
- Drug release rate was found to be significantly influenced by the pH of the release medium.
- The system successfully combined controlled release with magnetic targeting capabilities.
Conclusions:
- The developed chitosan/PAA coated magnetic hollow spheres represent a promising platform for controlled and targeted drug delivery.
- The pH-dependent release mechanism allows for tunable drug administration.
- This novel system holds significant potential for advancing drug delivery therapeutics.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...